The goal of the Yale Interdisciplinary Immunology Training Program (YIITP) is to equip predoctoral and postdoctoral trainees with the intellectual and research foundations necessary to become independent scientists/educators investigating the immune system and its roles in human disease. The YIITP combines rigorous research training in a highly collaborative, interactive environment with a thorough academic program of instruction in immunology, microbiology, and related disciplines. The program offers training in virtually all aspects of molecular, cellular, and genetic immunology as well as host-pathogen interactions and a variety of autoimmune and inflammatory disorders. Areas of particular strength include innate immune recognition and function, B and T lymphocyte development, tolerance, and memory, antigen processing and presentation, signaling by adaptive and innate immune cells, the immune response to infectious organisms (including a number of Biodefense Priority Pathogens), vascular endothelial cells, and autoimmune diseases such as diabetes and systemic lupus erythematosus. As a group, the 35 YIITP trainers have an outstanding record of research accomplishment and training and many are national or international leaders in their fields. These faculty have primary appointments in 10 different Yale departments and currently have 69 predoctoral and 152 postdoctoral trainees working in their labs. Predoctoral training leading to the Ph.D. degree involves formal course work in Immunology and other areas of biology, research rotations, teaching, and the qualifying exam in the first two years, with dissertation research beginning late in year one and becoming the primary focus of activity after completion of the qualifying exam. Intensive training in the methods, logic, and responsible conduct of research are supplemented with a wide array of opportunities for scientific interactions. The average time to obtain the Ph.D. degree is 5.5 years. Postdoctoral training focuses intensively on research in the laboratory of one or more of the trainers and is enriched by many opportunities for collaboration and interaction. The vast majority of YIITP trainees go on obtain independent research and teaching positions at academic institutions or research positions in biotechnology companies. Extensive efforts are made by YIITP trainers and Yale Graduate and Medical Schools to attract and retain trainees from diverse backgrounds, particularly underrepresented minority groups. This application requests funding to support 12 predoctoral and 3 postdoctoral trainees at any one time;they are supported by this grant for a maximum of 3 and 2 years, respectively. Relevance: This program trains scientists to pursue research careers focused on investigating the immune system, the system of the body responsible for combating infectious diseases. Such research is expected to yield new vaccines, new therapies to combat viruses and bacteria, and new treatments for autoimmune diseases such as diabetes, lupus, and rheumatoid arthritis and hypersensitivity disorders such as asthma.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007019-36
Application #
8106108
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
1976-07-01
Project End
2012-08-31
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
36
Fiscal Year
2011
Total Cost
$598,108
Indirect Cost
Name
Yale University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Fistonich, Chris; Zehentmeier, Sandra; Bednarski, Jeffrey J et al. (2018) Cell circuits between B cell progenitors and IL-7+ mesenchymal progenitor cells control B cell development. J Exp Med 215:2586-2599
Jurado, Kellie A; Yockey, Laura J; Wong, Patrick W et al. (2018) Antiviral CD8 T cells induce Zika-virus-associated paralysis in mice. Nat Microbiol 3:141-147
Molony, Ryan D; Malawista, Anna; Montgomery, Ruth R (2018) Reduced dynamic range of antiviral innate immune responses in aging. Exp Gerontol 107:130-135
Perry, Curtis J; Muñoz-Rojas, Andrés R; Meeth, Katrina M et al. (2018) Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med 215:877-893
Zhou, Xu; Franklin, Ruth A; Adler, Miri et al. (2018) Circuit Design Features of a Stable Two-Cell System. Cell 172:744-757.e17
Manfredo Vieira, S; Hiltensperger, M; Kumar, V et al. (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359:1156-1161
Greiling, Teri M; Dehner, Carina; Chen, Xinguo et al. (2018) Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med 10:
Yockey, Laura J; Jurado, Kellie A; Arora, Nitin et al. (2018) Type I interferons instigate fetal demise after Zika virus infection. Sci Immunol 3:
Pompura, Saige L; Dominguez-Villar, Margarita (2018) The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function. J Leukoc Biol :
Ring, Nan Guo; Herndler-Brandstetter, Dietmar; Weiskopf, Kipp et al. (2017) Anti-SIRP? antibody immunotherapy enhances neutrophil and macrophage antitumor activity. Proc Natl Acad Sci U S A 114:E10578-E10585

Showing the most recent 10 out of 152 publications